These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23914021)

  • 1. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.
    Virani SS
    Tex Heart Inst J; 2013; 40(3):288-9. PubMed ID: 23914021
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
    BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B; Altobelli KK; Williams K; Cannon CP; Pencina MJ; Sniderman AD; Thanassoulis G
    Circulation; 2017 Nov; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins.
    Ratchford EV; Martin SS
    Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Quality Statin Trials Support the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines After the HOPE-3 Trial (Heart Outcomes Prevention Evaluation-3): MESA (The Multiethnic Study of Atherosclerosis).
    Mortensen MB; Budoff M; Li D; Nasir K; Blaha MJ; Sandfort V; Jose Rodriguez C; Ouyang P; Falk E
    Circulation; 2017 Nov; 136(19):1863-1865. PubMed ID: 28634218
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary and Secondary Prevention of Acute Coronary Syndromes: The Role of the Statins.
    Diamantis E; Troupis T; Mazarakis A; Kyriakos G; Diamanti S; Troupis G; Skandalakis P
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):97-105. PubMed ID: 26152179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin efficacy in primary CVD prevention might diminish with patient age.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2019 Apr; 16(4):200. PubMed ID: 30783252
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: meta-regression of randomized placebo-controlled trials.
    Takagi H; Umemoto T;
    Int J Cardiol; 2013 Oct; 168(5):4850-3. PubMed ID: 23890857
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression-Brief Report.
    Labos C; Brophy JM; Smith GD; Sniderman AD; Thanassoulis G
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):262-265. PubMed ID: 29122815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
    Zhao B; He X; Wu J; Yan S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population-Based Cohort Study.
    Garcia-Gil M; Comas-Cufí M; Blanch J; Martí R; Ponjoan A; Alves-Cabratosa L; Petersen I; Marrugat J; Elosua R; Grau M; Ramos R
    Clin Pharmacol Ther; 2018 Oct; 104(4):719-732. PubMed ID: 29194590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
    Stam-Slob MC; Visseren FL; Wouter Jukema J; van der Graaf Y; Poulter NR; Gupta A; Sattar N; Macfarlane PW; Kearney PM; de Craen AJ; Trompet S
    Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins in the primary prevention of cardiovascular disease.
    Reiner Ž
    Nat Rev Cardiol; 2013 Aug; 10(8):453-64. PubMed ID: 23736519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
    BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in women for primary prevention--is there evidence to back up their use??
    Fenton A; Panay N
    Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236
    [No Abstract]   [Full Text] [Related]  

  • 20. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.